Halozyme Therapeutics
FeaturedIndustry NewsLeasingLife ScienceSan Diego
Pfizer’s 518,000 SQFT Exit Sinks Torrey Pines Absorption as Availability Drops, While Del Mar Heights Tightens to 10.3% Lab Vacancy
Pfizer's departure from the last 518,262 square feet of its former Torrey Pines campus gave San Diego's premier lab submarket the region's worst...
AECFeaturedFinanceIndustry NewsLife ScienceSan Diego
San Diego Lab R&D Leasing Holds Steady as Capital Flows Offset Elevated Vacancy
Q4 activity reaches 283,000 square feet while large fundraises reinforce confidence in core biotech submarkets After a period defined more by consolidation than...
CommercialFinanceIndustry NewsLife ScienceNews ReleasesSan Diego
Halozyme Therapeutics Leases 72,534 SQFT at Del Mar Corporate Centre in San Diego
SAN DIEGO, Calif., – June 15, 2022 – Cushman & Wakefield announced that Halozyme Therapeutics, a biopharmaceutical company bringing disruptive solutions to significantly...
